Floatz logo

8 assets in Extrahepatic Bile Duct Carcinoma

Therapeutic assets addressing Extrahepatic Bile Duct Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Fluorouracilum
Extrahepatic Bile Duct Carcinoma
Lisata Therapeutics, Inc.P2BBB (72)
Oxaliplatin
Extrahepatic Bile Duct Carcinoma
Lisata Therapeutics, Inc.P3BB (70)
Cis-Diamminedichloroplatinum Ii
Extrahepatic Bile Duct Carcinoma
Lisata Therapeutics, Inc.P2BB (64)
Durvalumab
Extrahepatic Bile Duct Carcinoma
Lisata Therapeutics, Inc.P2CCC (53)
Ipilimumab
Extrahepatic Bile Duct Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Nivolumab
Extrahepatic Bile Duct Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Certepetide
Extrahepatic Bile Duct Carcinoma
Lisata Therapeutics, Inc.P2CCC (49)
Copper Cu 64 Anti-Cea Monoclonal Antibody M5A
Extrahepatic Bile Duct Carcinoma
City of Hope Medical CenterN/AD (30)